Sign up for the TRISH newsletter to receive updates about funding opportunities. The Institute is unable to provide specific details regarding the timeline or release of future solicitations at this time.
Biomedical Research Advances for Space Health (2201 BRASH)
TRISH is seeking scientific proposals for disruptive technologies, therapies and/or approaches to protecting astronaut health through enhancing pre-existing internal cellular repair functions.
Deep space exploration comes with multiple physiological and psychological stressors for astronauts, including increased radiation exposure, gravity changes, isolation and confinement, and an omnipresent hostile/dangerous environment. These stressors negatively impact health through tissue degradation, DNA damage, cell death, neurological changes, and more.
The BRASH 2201 solicitation seeks ways to reduce multiple crew health risks while enhancing the body’s ability to control endogenous repair and maintenance processes to support optimal organ, tissue, and cell function for astronauts.
Step-1 proposals are due on Jan. 26, 2022, by 5 p.m. ET. Selections will be announced in October 2022. View the pre-proposal webinar recording from Dec. 17, 2021.
TRISH Postdoctoral Fellowship (RFA 2201 PD)
TRISH is seeking research proposals from postdoctoral fellows ready to help solve the challenges of space exploration.
TRISH’s postdoctoral fellowship program supports early-career scientists pursuing innovative, breakthrough research with the potential to reduce spaceflight associated health risks and improve astronaut performance. Selected fellows will participate in TRISH’s Academy of Bioastronautics. Fellows will receive a stipend for salary support for two years, with a chance for a third year of funding.
Applications are due on Jan. 20, 2022, by 5 p.m. ET. Selections will be announced in May 2022.
Catalyst Proposals grants are unsolicited proposals that may be submitted at any time. This funding vehicle is best suited for pilot or proof-of-principle projects with a small amount of funding and a short duration.
TRISH Catalyst funds are fully obligated at this time.
Schedule: Unsolicited or directed. Submit any time.
Annual Funding Amount: Generally less than $100,000 but can be up to $350,000
Duration: Up to two years
Review: Programmatic relevance and external scientific peer reviews. Reviewed as received.
TRISH Cost Sharing Requirements
Areas of Interest